ACRS insider buying
Aclaris Therapeutics, Inc.
Every qualifying open-market purchase of ACRS reported to the SEC on Form 4, parsed directly from the filings and linked back to the source on EDGAR. No buying cluster — two or more distinct insiders inside a rolling window — has been detected in ACRS yet; if one forms, it appears here (and hits our alert subscribers in real time).
All notable open-market buys in ACRS
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Nov 19, 2024 | Director | 666,666 | $2.25 | $1.5M | SEC ↗ |
| Aug 5, 2024 | 10% Owner | 206,025 | $1.24 | $255.5K | SEC ↗ |
| Aug 2, 2024 | 10% Owner | 167,544 | $1.29 | $216.1K | SEC ↗ |
| Jul 31, 2024 | 10% Owner | 100,000 | $1.33 | $133.0K | SEC ↗ |
| Jul 30, 2024 | 10% Owner | 173,730 | $1.30 | $225.8K | SEC ↗ |
| Jul 18, 2024 | 10% Owner | 130,317 | $1.30 | $169.4K | SEC ↗ |
| Jul 5, 2024 | 10% Owner | 123,017 | $1.15 | $141.5K | SEC ↗ |
| Jul 3, 2024 | 10% Owner | 143,288 | $1.16 | $166.2K | SEC ↗ |
| Jul 1, 2024 | 10% Owner | 107,434 | $1.14 | $122.5K | SEC ↗ |
| Jun 28, 2024 | 10% Owner | 801,000 | $1.12 | $897.1K | SEC ↗ |
| Jun 28, 2024 | 10% Owner | 400,000 | $1.13 | $452.0K | SEC ↗ |
| Jun 27, 2024 | 10% Owner | 235,000 | $1.15 | $270.3K | SEC ↗ |
| Jun 17, 2024 | 10% Owner | 150,000 | $1.13 | $169.5K | SEC ↗ |
| Jun 14, 2024 | 10% Owner | 345,000 | $1.17 | $403.7K | SEC ↗ |
| Jun 13, 2024 | 10% Owner | 500,000 | $1.15 | $575.0K | SEC ↗ |
| Jun 11, 2024 | 10% Owner | 1,000,000 | $1.08 | $1.1M | SEC ↗ |
ACRS insider buying — FAQ
- Are insiders buying ACRS stock?
- 2 insiders have bought ACRS (Aclaris Therapeutics, Inc.) on the open market, most recently on Nov 20, 2024. No cluster buy — two or more distinct insiders within a rolling window — has been detected yet.
- How much ACRS stock have insiders bought?
- Insiders have bought a combined $6.8M of ACRS across 16 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in ACRS?
- A cluster buy is two or more distinct Aclaris Therapeutics, Inc. insiders — officers, directors, or 10% owners — each buying ACRS on the open market within a rolling window. None has been detected in ACRS yet.
- Where does this ACRS insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in ACRS
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy ACRS within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding ACRS.